{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:08:13Z","timestamp":1789132093668,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuroscience.2026.07.065","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:20:51Z","timestamp":1785453651000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Depression and amyloid-\u03b2 across CSF, PET, and plasma biomarkers: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"614","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3093-0160","authenticated-orcid":false,"given":"Chushu","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.07.065_b0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-191078","article-title":"Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults","volume":"74","author":"Babulal","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0010","first-page":"19","article-title":"Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression","volume":"2025","author":"Bertollo","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13550-025-01260-4","article-title":"Kinetic modeling of (18)F-PI-2620 binding in the brain using an image-derived input function with total-body PET","volume":"15","author":"Bhattarai","year":"2025","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnagi.2016.00236","article-title":"Association of cerebral amyloidosis, blood pressure, and neuronal injury with late-life onset depression","volume":"8","author":"Byun","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/geronb\/gbu096","article-title":"Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression","volume":"69","author":"Diniz","year":"2014","journal-title":"J. Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpsychires.2012.12.008","article-title":"Plasma amyloid \u03b2, depression, and dementia in community-dwelling elderly","volume":"47","author":"Direk","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-142940","article-title":"Depressive symptoms and biomarkers of Alzheimer's disease in cognitively normal older adults","volume":"46","author":"Donovan","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jagp.2023.04.014","article-title":"Lipopolysaccharide, immune biomarkers and cerebral amyloid-beta deposition in older adults with mild cognitive impairment & major depressive disorder","volume":"31","author":"Feng","year":"2023","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.neuropsych.20230043","article-title":"Depression as a risk factor for dementia: a meta-analysis","volume":"36","author":"Fern\u00e1ndez","year":"2024","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0050","doi-asserted-by":"crossref","first-page":"e198964","DOI":"10.1001\/jamanetworkopen.2019.8964","article-title":"Longitudinal association of depression symptoms with cognition and cortical amyloid among community-dwelling older adults","volume":"2","author":"Gatchel","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JGP.0b013e3180547091","article-title":"The relationship between cerebrospinal fluid biomarkers and depression in elderly women","volume":"15","author":"Gudmundsson","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0060","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1038\/s41380-020-0754-0","article-title":"Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group","volume":"26","author":"Han","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-022-00898-8","article-title":"Impact of cerebral blood flow and amyloid load on SUVR bias","volume":"12","author":"Heeman","year":"2022","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-2010-100207","article-title":"Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years","volume":"21","author":"Hertze","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.07.037","article-title":"Parametric imaging and quantitative analysis of the PET amyloid ligand [18F]flutemetamol","volume":"121","author":"Heurling","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hbm.24988","article-title":"Subcortical shape alterations in major depressive disorder: findings from the ENIGMA major depressive disorder working group","volume":"43","author":"Ho","year":"2022","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.26439","article-title":"Application of the amyloid\/tau\/neurodegeneration framework in cognitively intact adults: the CABLE Study","volume":"92","author":"Hu","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2967\/jnumed.123.265766","article-title":"Quantitative brain amyloid PET","volume":"65","author":"Jagust","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0095","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1002\/alz.12557","article-title":"Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging","volume":"19","author":"Krell-Roesch","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0100","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archgenpsychiatry.2011.122","article-title":"Protein binding in patients with late-life depression","volume":"68","author":"Kumar","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.14283\/jpad.2022.13","article-title":"Anxiety and depressive symptoms and cortical amyloid-\u03b2 burden in cognitively unimpaired older adults","volume":"9","author":"Lewis","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021371","article-title":"The synergic effect of AT(N) profiles and depression on the risk of conversion to dementia in patients with mild cognitive impairment","volume":"24","author":"Marqui\u00e9","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11101298","article-title":"HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation","volume":"11","author":"Mikulska","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0120","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.pnpbp.2011.05.013","article-title":"The correlation of plasma A\u03b242 levels, depressive symptoms, and cognitive function in the Korean elderly","volume":"35","author":"Moon","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0125","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1038\/s41380-020-0766-9","article-title":"Excess tau PET ligand retention in elderly patients with major depressive disorder","volume":"26","author":"Moriguchi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0135","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of fully automated plasma assays as screening tests for Alzheimer disease\u2013related \u03b2-amyloid status","volume":"76","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3988\/jcn.2022.18.4.401","article-title":"Promising blood biomarkers for clinical use in Alzheimer\u2019s disease: a focused update","volume":"18","author":"Park","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0145","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","article-title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","volume":"49","author":"Pemberton","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1755-5949.2012.00311.x","article-title":"Cerebrospinal fluid biomarkers in Alzheimer's disease and geriatric depression: preliminary findings from Brazil","volume":"18","author":"Reis","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091809","article-title":"Depression as a risk factor for Alzheimer's disease: a systematic review of longitudinal meta-analyses","volume":"10","author":"S\u00e1iz-V\u00e1zquez","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0165","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0170","doi-asserted-by":"crossref","first-page":"20375","DOI":"10.1038\/s41598-021-99794-9","article-title":"Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","volume":"11","author":"Siafarikas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WAD.0b013e31819cb3ac","article-title":"Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele","volume":"23","author":"Sun","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuroscience.2026.07.065_b0180","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/gps.4215","article-title":"Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset","volume":"30","author":"Tateno","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0185","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1038\/s41380-022-01772-8","article-title":"Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network","volume":"27","author":"Touron","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41398-024-02739-9","article-title":"Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis","volume":"14","author":"Twait","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0195","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41386-021-01072-9","article-title":"Default mode network dissociation linking cerebral beta amyloid retention and depression in cognitively normal older adults","volume":"46","author":"Wang","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac272","article-title":"Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta","volume":"4","author":"Weigand","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0205","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00259-013-2627-0","article-title":"Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45\/Amyvid) positron emission tomography","volume":"41","author":"Wu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroscience.2026.07.065_b0210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2967\/jnumed.111.095927","article-title":"Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies","volume":"53","author":"Zhou","year":"2012","journal-title":"J. Nucl. Med."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600521X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600521X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:27:41Z","timestamp":1789129661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222600521X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S030645222600521X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.07.065","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression and amyloid-\u03b2 across CSF, PET, and plasma biomarkers: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}